Single-Patient Expanded Access Requests: IRB Professionals’ Experiences and Perspectives-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Single-Patient Expanded Access Requests: IRB Professionals’ Experiences and Perspectives

Published:2019-04-03 Issue:2 Volume:10 Page:88-99
ISSN:2329-4515
Container-title:AJOB Empirical Bioethics
language:en
Short-container-title:AJOB Empirical Bioethics

Author:

Chapman Carolyn Riley¹,Shearston Jenni A.²,Folkers Kelly McBride¹,Redman Barbara K.¹,Caplan Arthur¹,Bateman-House Alison¹

Affiliation:

1. Division of Medical Ethics, Department of Population Health, NYU School of Medicine, NYU Langone Health, New York, New York, USA;

2. Departments of Population Health, Environmental Medicine, and Pediatrics, NYU School of Medicine, NYU Langone Health, New York, New York, USA

Publisher

Informa UK Limited

Subject

Health Policy,Philosophy,Health(social science)

Link

https://www.tandfonline.com/doi/pdf/10.1080/23294515.2019.1577192

Reference23 articles.

1. Right-to-Try Laws: Hope, Hype, and Unintended Consequences

2. The Federal Right to Try Act of 2017—A Wrong Turn for Access to Investigational Drugs and the Path Forward

3. Ethics review in compassionate use

4. Practical, Legal, and Ethical Issues in Expanded Access to Investigational Drugs

5. Improving Expanded Access in the United States: The Role of the Institutional Review Board

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FDA Approval for Phytochemicals in the Treatment of Cancer;Phytonutrients in the Treatment of Gastrointestinal Cancer;2023-04-27

2. Investigational Medical Products for Rare Diseases: Ethical Concerns and Unresolved Issues with Expanded Access;Clinical OMICs;2021-11-01

3. A survey of pediatric hematologists/oncologists’ perspectives on single patient Expanded Access and Right to Try;Medicine Access @ Point of Care;2021-01

4. Oversight of Right‐to‐Try and Expanded Access Requests for Off‐Trial Access to Investigational Drugs;Ethics & Human Research;2020-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3